General Information of the Compound
| Compound ID |
CP0433393
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2R)-2-[(8S)-1-chloro-8-[2-[2,5-difluoro-4-(trifluoromethyl)phenyl]ethyl]-3-ethyl-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]-N-methyl-2-phenylacetamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H26ClF5N4O
|
||||||||||||||||||
| Molecular Weight |
540.964
|
||||||||||||||||||
| Canonical SMILES |
CCc1nc(Cl)c2[C@H](CCc3cc(F)c(cc3F)C(F)(F)F)N(CCn12)[C@@H](C(=O)NC)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H26ClF5N4O/c1-3-21-34-24(27)23-20(10-9-16-13-19(29)17(14-18(16)28)26(30,31)32)35(11-12-36(21)23)22(25(37)33-2)15-7-5-4-6-8-15/h4-8,13-14,20,22H,3,9-12H2,1-2H3,(H,33,37)/t20-,22+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
RJLZDLBYNVLDFY-RBBKRZOGSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01132, Orexin receptor type 2
Protein ID: PT02001, Orexin/Hypocretin receptor type 1